Vera Рузинова

Ms. Vera Рузинова


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VРVera Рузинова
Vera Рузинова
YDYu. V. Dolgopolova
Yu. V. Dolgopolova
DPDmitry Petelin
Dmitry Petelin
OSO. Yu. Sorokina
O. Yu. Sorokina
Beatrice VolelBeatrice Volel
Beatrice Volel
In the past decades, biofeedback has become a widely adopted non-pharmacological option in the management of a variety of somatic, neurological, and psychiatric conditions. The biofeedback method is based on the associations between one’s vegetative and mental functions; during a session with the device, information about the change in his/her condition over time is “returned” to the patient as accessible audial or visual stimuli. The efficacy of biofeedback treatment may primarily be attributed to improvements in the state of the patients based on establishing an individual model of his/her best psychophysiological state, enabling effective rehabilitation activities at a rate suitable for each patient along with ensuring better awareness of the patient of his/her body functions; such an intervention is stepwise and helps sustain the patient’s motivation for success, thus affecting the pathological condition. This review describes the historical prerequisites for the development of biofeedback techniques and the principal mechanisms of their action; a brief summary of studies looking at the efficacy of this method in various somatic, neurological, and psychiatric conditions is also provided. The presented data clearly indicate that the use of biofeedback results in a decreased medication load in patients suffering from conditions such as arterial hypertension, epilepsy, ADHD, chronic pain, anxiety disorders, autism etc. while there are practically no contraindications for this method, except for acute psychosis, photosensitive epilepsy, and severe cognitive impairment. In this connection, clinical implementation of biofeedback techniques should be intensified in a variety of conditions.

14 May 2025 in Clinical Psychology and Special Education
Verified
Journal Article
Open access
PDF file
VРVera Рузинова
Vera Рузинова
MKMaria G. Kiseleva
Maria G. Kiseleva
BVB.A. Vovel
B.A. Vovel
ZKZ.R. Kushu
Z.R. Kushu
This study is intended to determine the preliminary effectiveness of a short-term 10-day program for the treatment of anxiety disorders using methods of mindfulness formation using biofeedback (biofeedback). The sample size was 94 patients of the psychotherapy department of the Clinic of Nervous Diseases named after A.Y. Kozhevnikov Clinical Center of Sechenov University (68.1% women and 31.9% men) with a mean age of years (M = 43.52, SD = 13.58) met the study criteria and completed the program. Subjects were randomized into three groups: (1) mindfulness program using adaptive biocontrol methods (without medication support) (OBT — mindfulness and biofeedback), (2) medication treatment of anxiety disorder (MT — medication therapy), and (3) combination of medication therapy methods and mindfulness program using biofeedback methods (CT — combination therapy). Outcomes were assessed at baseline, after 10 days of treatment, and 1 month post-treatment. At the end-of-program follow-up point, patients whose therapy programs included a short-term program of mindfulness and biofeedback practices (OBT and CT groups) showed the best results in reducing anxiety, somatic symptoms, and increasing mindfulness factors. The results were maintained during a one-month follow-up period. The results warrant a larger study to identify predictors of therapy.

15 July 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
AKAnastasia Vladimirovna Kotelnikova
Anastasia Vladimirovna Kotelnikova
VРVera Рузинова
Vera Рузинова
MKMaria G. Kiseleva
Maria G. Kiseleva
Beatrice VolelBeatrice Volel
Beatrice Volel
AKAnastasia Kukshina
Anastasia Kukshina
Background: Anxiety disorders are prevalent and debilitating. Given challenges in maintaining mindfulness at one-month remission, integrative approaches targeting anxiety and psychological resources (especially mindfulness) have gained interest. This study aimed to assess the effectiveness of adding biofeedback to the treatment of anxiety disorders. Methods: Inpatients with anxiety disorder (ICD10 F40/F41) were randomized to three groups: (1) biofeedback for enhancing mindfulness (BFB, n = 76); (2) medication therapy (MT, escitalopram 10 mg/day, n = 46); and (3) combined therapy (BFB + MT, CT, n = 66). Per-protocol analysis: 180 completers; ITT: all 188 randomized patients. The primary outcomes were changes in the Hamilton Anxiety Rating Scale (HAM-A) total score and the Five Facet Mindfulness Questionnaire total score, assessed at baseline, after 10 days of treatment, and at one-month follow-up. The HAM-A assessor was blinded to group allocation. Results: In the per-protocol analysis, the BFB and CT groups showed a significantly greater reduction in the HAM-A score than the MT group did. For example, post-treatment, the mean difference between BFB and MT groups was –6.30 points (95% CI: –9.12 to –3.48, p = 0.00046). The BFB and CT groups did not differ significantly. For mindfulness, the BFB and CT groups showed an increase, whereas the MT group showed a decrease (BFB vs. MT: mean difference 30.28 points, 95% CI: 23.54–37.02, p < 0.000001). Intention-to-treat (ITT) analysis (n = 188) confirmed the robustness of these findings. Conclusions: BFB appears to be a promising approach for reducing anxiety and fostering mindfulness skills; these findings suggest it may be worth exploring further as a potential component of comprehensive therapy for anxiety disorders. Clinical Trial Registration: ClinicalTrials.gov NCT07628153 (retrospectively registered). The trial was retrospectively registered, and the primary analysis was conducted on a per-protocol population.

28 April 2026 in Bulletin of psychotherapy
Verified
Journal Article
Open access
PDF file
VРVera Рузинова
Vera Рузинова
AKAnastasia Vladimirovna Kotelnikova
Anastasia Vladimirovna Kotelnikova
MKMaria G. Kiseleva
Maria G. Kiseleva
NZN. I. Zentsova
N. I. Zentsova
Relevance. Anxiety disorders affect over 4 % of the global population, significantly impairing quality of life and creating a substantial burden on healthcare systems. The limited efficacy of existing treatment modalities necessitates the exploration of novel therapeutic approaches. Objective. To conduct a systematic analysis and integration of data regarding the potential of various psychotherapeutic approaches to develop mindfulness components in patients with anxiety disorders based on the Five-Facet Model. Methodology . A systematic literature review was conducted using PubMed, Google Scholar, CyberLeninka, and eLIBRARY databases for publications from 2000 to 2024. Comparative and systematic analysis methods were employed to identify mechanisms through which different therapeutic paradigms impact mindfulness components. Results and а nalysis . The study revealed distinct intervention profiles of different approaches: mindfulness-based cognitive therapy demonstrated efficacy in developing observation, conscious actions, and non-reactivity; dalectical behavior therapy was most effective for developing description and conscious actions; acceptance and commitment therapy proved effective for developing nonreactivity and absence of reactivity; psychoanalysis primarily fostered observation skills. Conclusion. The Five-Facet Mindfulness Model represents a practical tool for developing individualized psychotherapy protocols. The utilization of the Five-Facet Mindfulness Questionnaire (FFMQ) is recommended for diagnostic assessment and selection of relevant psychocorrection methods.

9 November 2026 in SibScript
Verified
Journal Article
Closed access
AKAnastasia Vladimirovna Kotelnikova
Anastasia Vladimirovna Kotelnikova
VРVera Рузинова
Vera Рузинова
MKMaria G. Kiseleva
Maria G. Kiseleva
NZNatalia I. Zentsova
Natalia I. Zentsova
Anxiety disorders are a widespread mental pathology, yet standard pharmacotherapy often fails to provide sustained remission. Adaptive biofeedback and mindfulness training are effective psychological correction methods, although the clinical and psychological profile of patients who are most responsive to these interventions remains understudied. This research aimed to predict the effectiveness of biofeedback training in cultivating mindfulness in patients with anxiety disorders. This prospective randomized controlled trial included 180 patients (coded F40 and F41 under ICD-10) divided into three groups: isolated biofeedback training (n = 76), combined therapy (biofeedback training plus pharmacotherapy, n = 58), and medication monotherapy (n = 46). The assessment tools included the Hamilton Anxiety Rating Scale, the Five Facet Mindfulness Questionnaire, the Toronto Alexithymia Scale, and functional diagnostics (EEG alpha-rhythm asymmetry and power). The statistical analysis employed analyses of variance (ANOVA). The predominating somatic component in the isolated biofeedback group was associated with a sustained increase in alpha rhythm at follow-up. In patients with predominantly psychic anxiety, the achieved increase was not maintained. Alexithymia emerged as a significant predictor. In the acute phase, the biofeedback training promoted the verbal component of mindfulness (the Describe subscale). At follow-up, it provided a higher overall level of mindfulness and stable anxiety reduction compared to isolated pharmacotherapy (p ≤ 0.05). The patients with low alexithymia demonstrated no significant differences between treatment modalities. Thus, the level of alexithymia and the structure of anxiety symptoms proved to be informative clinical and psychological predictors for tailoring biofeedback training. In this study, the patients with high or moderate alexithymia and somatic anxiety proved to be especially susceptible to the method.